Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3050683rdf:typepubmed:Citationlld:pubmed
pubmed-article:3050683lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:3050683lifeskim:mentionsumls-concept:C1299003lld:lifeskim
pubmed-article:3050683lifeskim:mentionsumls-concept:C0020835lld:lifeskim
pubmed-article:3050683lifeskim:mentionsumls-concept:C0205132lld:lifeskim
pubmed-article:3050683pubmed:issue3lld:pubmed
pubmed-article:3050683pubmed:dateCreated1988-11-3lld:pubmed
pubmed-article:3050683pubmed:abstractTextThe ocular history and examination of a 54-year-old Filipino woman with linear IgA disease is described. Results of the eye examination were consistent with chronic cicatricial conjunctivitis, showing subconjunctival fibrosis and symblepharon formation. Direct immunofluorescence of the conjunctiva was positive for IgA and C3 in a linear pattern along the epithelial basement membrane. The ophthalmologic and dermatologic findings in linear IgA disease are compared with those of dermatitis herpetiformis, bullous pemphigoid, and cicatricial pemphigoid. This is the first documented case report of the ocular manifestations of linear IgA disease in the American literature.lld:pubmed
pubmed-article:3050683pubmed:languageenglld:pubmed
pubmed-article:3050683pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3050683pubmed:citationSubsetIMlld:pubmed
pubmed-article:3050683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3050683pubmed:statusMEDLINElld:pubmed
pubmed-article:3050683pubmed:monthMarlld:pubmed
pubmed-article:3050683pubmed:issn0161-6420lld:pubmed
pubmed-article:3050683pubmed:authorpubmed-author:DonnenfeldE...lld:pubmed
pubmed-article:3050683pubmed:authorpubmed-author:StarrM BMBlld:pubmed
pubmed-article:3050683pubmed:authorpubmed-author:AultbrinkerE...lld:pubmed
pubmed-article:3050683pubmed:issnTypePrintlld:pubmed
pubmed-article:3050683pubmed:volume95lld:pubmed
pubmed-article:3050683pubmed:ownerNLMlld:pubmed
pubmed-article:3050683pubmed:authorsCompleteYlld:pubmed
pubmed-article:3050683pubmed:pagination340-3lld:pubmed
pubmed-article:3050683pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:meshHeadingpubmed-meshheading:3050683-...lld:pubmed
pubmed-article:3050683pubmed:year1988lld:pubmed
pubmed-article:3050683pubmed:articleTitleLinear IgA disease. The ocular manifestations.lld:pubmed
pubmed-article:3050683pubmed:affiliationDepartment of Ophthalmology, Manhattan Eye, Ear and Throat Hospital, New York, NY 10021.lld:pubmed
pubmed-article:3050683pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3050683pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3050683lld:pubmed